These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 19665407

  • 1. Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
    Chang HH, Lee NY, Ko WC, Lee HC, Yang YH, Wu CJ, Chang CM.
    Int J Infect Dis; 2010 Apr; 14(4):e348-50. PubMed ID: 19665407
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Mori T, Aisa Y, Kato J, Nakamura Y, Ikeda Y, Okamoto S.
    Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
    [Abstract] [Full Text] [Related]

  • 4. Voriconazole inhibition of tacrolimus metabolism.
    Pai MP, Allen S.
    Clin Infect Dis; 2003 Apr 15; 36(8):1089-91. PubMed ID: 12684931
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    Pea F, Baccarani U, Tavio M, Cojutti P, Adani GL, Londero A, Baraldo M, Franceschi L, Furlanut M, Viale P.
    Ann Pharmacother; 2008 Nov 15; 42(11):1711-6. PubMed ID: 18812562
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes.
    Zhang S, Pillai VC, Mada SR, Strom S, Venkataramanan R.
    Xenobiotica; 2012 May 15; 42(5):409-16. PubMed ID: 22106961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM.
    Transpl Infect Dis; 2009 Jun 15; 11(3):211-9. PubMed ID: 19302272
    [Abstract] [Full Text] [Related]

  • 12. [Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
    Ogaki K, Noda K, Fukae J, Furuya T, Hirayama T, Fujishima K, Hattori N, Okuma Y.
    Brain Nerve; 2010 Dec 15; 62(12):1337-40. PubMed ID: 21139187
    [Abstract] [Full Text] [Related]

  • 13. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S.
    J Med Assoc Thai; 2006 Jun 15; 89(6):795-802. PubMed ID: 16850679
    [Abstract] [Full Text] [Related]

  • 14. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G, Discher T, Füssle R, Schmalreck A, Lohmeyer J.
    AIDS; 2001 Nov 23; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract] [Full Text] [Related]

  • 15. Cryptococcal meningitis presenting as sinusitis in a renal transplant recipient.
    Iyer SP, Movva K, Wiebel M, Chandrasekar P, Alangaden G, Carron M, Tranchida P, Revankar SG.
    Transpl Infect Dis; 2013 Oct 23; 15(5):E187-90. PubMed ID: 24034280
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New guinea pig model of Cryptococcal meningitis.
    Kirkpatrick WR, Najvar LK, Bocanegra R, Patterson TF, Graybill JR.
    Antimicrob Agents Chemother; 2007 Aug 23; 51(8):3011-3. PubMed ID: 17562797
    [Abstract] [Full Text] [Related]

  • 19. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
    Mondon P, Petter R, Amalfitano G, Luzzati R, Concia E, Polacheck I, Kwon-Chung KJ.
    Antimicrob Agents Chemother; 1999 Aug 23; 43(8):1856-61. PubMed ID: 10428902
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.